Epidermal growth factor receptor signalling in human breast cancer cells operates parallel to estrogen receptor α signalling and results in tamoxifen insensitive proliferation

BACKGROUND: Tamoxifen resistance is a major problem in the treatment of estrogen receptor (ER) α -positive breast cancer patients. Although the mechanisms behind tamoxifen resistance are still not completely understood, clinical data suggests that increased expression of receptor tyrosine kinases is...

Descripción completa

Detalles Bibliográficos
Autores principales: Moerkens, Marja, Zhang, Yinghui, Wester, Lynn, van de Water, Bob, Meerman, John HN
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4021213/
https://www.ncbi.nlm.nih.gov/pubmed/24758408
http://dx.doi.org/10.1186/1471-2407-14-283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4021213/
https://www.ncbi.nlm.nih.gov/pubmed/24758408
http://dx.doi.org/10.1186/1471-2407-14-283

Ejemplares similares